DEMIRELA TELJIGOVIC: Open Payments
NPI 1417781170 · WEST VALLEY CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 2 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| PFIZER INC. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: ZORYVE, Kerendia, JARDIANCE, GVOKE HYPOPEN, UBRELVY, OPSUMIT, VYNDAMAX, Wegovy.
Industry payments across UT — which companies pay providers there.
